Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7345)
All Articles published online
|
Publishing Process of This Article
|
Sep 28, 2015 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Liu H, Xu HW, Zhang YZ, Huang Y, Han GQ, Liang TJ, Wei LL, Qin CY, Qin CK. Ursodeoxycholic acid induces apoptosis in hepatocellular carcinoma xenografts in mice. World J Gastroenterol 2015; 21(36): 10367-10374 [PMID: 26420963 DOI: 10.3748/wjg.v21.i36.10367] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v21/i36/10367.htm |
| Number | Citing Articles |
| 1 |
Jin Lee, Eun Mi Hong, Kyung Joo Lee, Se Woo Park, Dong Hee Koh. Ursodeoxycholic Acid Suppresses Epithelial-Mesenchymal Transition via Inhibition of Reactive Oxygen Species in Bile Duct Cancer Cells. The Korean Journal of Pancreas and Biliary Tract 2024; 29(1): 9 doi: 10.15279/kpba.2024.29.1.9
|
| 2 |
Jonathan P. Jacobs, Tien S. Dong, Vatche Agopian, Venu Lagishetty, Vinay Sundaram, Mazen Noureddin, Walid S. Ayoub, Francisco Durazo, Jihane Benhammou, Pedram Enayati, David Elashoff, Marc T. Goodman, Joseph Pisegna, Shehnaz Hussain. Microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis: The Microbiome, Microbial Markers and Liver Disease Study. Hepatology Research 2018; 48(13): 1108 doi: 10.1111/hepr.13207
|
| 3 |
Tadeja Režen, Damjana Rozman, Tünde Kovács, Patrik Kovács, Adrienn Sipos, Péter Bai, Edit Mikó. The role of bile acids in carcinogenesis. Cellular and Molecular Life Sciences 2022; 79(5) doi: 10.1007/s00018-022-04278-2
|
| 4 |
Fan Wu, Ting-Yue Li, Shu-Chao Su, Ji-Shang Yu, Hao-Lu Zhang, Guo-Qian Tan, Jian-Wei Liu, Bai-Lin Wang. STC2 as a novel mediator for Mus81-dependent proliferation and survival in hepatocellular carcinoma. Cancer Letters 2017; 388: 177 doi: 10.1016/j.canlet.2016.11.039
|
| 5 |
Miao Xu, Qi Zhao, Donghui Shao, Hui Liu, Jianni Qi, Chengyong Qin. Chenodeoxycholic Acid Derivative HS-1200 Inhibits Hepatocarcinogenesis and Improves Liver Function in Diethylnitrosamine-Exposed Rats by Downregulating MTH1. BioMed Research International 2017; 2017: 1 doi: 10.1155/2017/1465912
|
| 6 |
Jing Liu, Nan Shao, Hui Qiu, Juanjuan Zhao, Chao Chen, Jiajia Wan, Zhixu He, Xu Zhao, Lin Xu. Intestinal microbiota: A bridge between intermittent fasting and tumors. Biomedicine & Pharmacotherapy 2023; 167: 115484 doi: 10.1016/j.biopha.2023.115484
|
| 7 |
Rômulo S. Cavalcante, Uta Ishikawa, Emanuell S. Silva, Arnóbio A. Silva‐Júnior, Aurigena A. Araújo, Luis J. Cruz, Alan B. Chan, Raimundo F. de Araújo Júnior. STAT3/NF‐κB signalling disruption in M2 tumour‐associated macrophages is a major target of PLGA nanocarriers/PD‐L1 antibody immunomodulatory therapy in breast cancer. British Journal of Pharmacology 2021; 178(11): 2284 doi: 10.1111/bph.15373
|
| 8 |
Zhi Yong Shen, Bei Qi Shen, Ai Jun Shen, Xin Hua Zhu. Cavitation-Enhanced Delivery of the Nanomaterial Graphene Oxide-Doxorubicin to Hepatic Tumors in Nude Mice Using 20 kHz Low-Frequency Ultrasound and Microbubbles. Journal of Nanomaterials 2020; 2020: 1 doi: 10.1155/2020/3136078
|
| 9 |
Jung Yoon Jang, Eunok Im, Yung Hyun Choi, Nam Deuk Kim. Mechanism of Bile Acid-Induced Programmed Cell Death and Drug Discovery against Cancer: A Review. International Journal of Molecular Sciences 2022; 23(13): 7184 doi: 10.3390/ijms23137184
|
| 10 |
V. T. Ivashkin, M. V. Maevskaya, M. S. Zharkova, Yu. V. Kotovskaya, O. N. Tkacheva, E. A. Troshina, M. V. Shestakova, I. V. Maev, V. V. Breder, N. I. Gheivandova, V. L. Doshchitsin, E. N. Dudinskaya, E. V. Ershova, Kh. B. Kodzoeva, K. A. Komshilova, N. V. Korochanskaya, A. Yu. Mayorov, E. E. Mishina, M. Yu. Nadinskaya, I. G. Nikitin, N. V. Pogosova, A. I. Tarzimanova, M. Sh. Shamkhalova. Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatricians and National Society for Preventive Cardiology on Diagnosis and Treatment of Non-Alcoholic Liver Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 32(4): 104 doi: 10.22416/1382-4376-2022-32-4-104-140
|
| 11 |
Xianfeng Wang, Zheng Chen, Dingrui Nie, Xiangbo Zeng, Mengjun Zhong, Xin Liu, Shuxin Zhong, Liang Wang, Ziwei Liao, Cunte Chen, Yangqiu Li, Chengwu Zeng. CASP1 is a target for combination therapy in pancreatic cancer. European Journal of Pharmacology 2023; 961: 176175 doi: 10.1016/j.ejphar.2023.176175
|
| 12 |
Marina V. Maevskaya, Yulia V. Kotovskaya, Vladimir T. Ivashkin, Olga N. Tkacheva, Ekaterina A. Troshina, Marina V. Shestakova, Valeriy V. Breder, Natalia I. Geyvandova, Vladimir L. Doshchitsin, Ekaterina N. Dudinskaya, Ekaterina V. Ershova, Khava B. Kodzoeva, Ksenia A. Komshilova, Natalia V. Korochanskaya, Alexander Yu. Mayorov, Ekaterina E. Mishina, Maria Yu. Nadinskaya, Igor G. Nikitin, Nana V. Pogosova, Aida I. Tarzimanova, Minara Sh. Shamkhalova. The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities. Terapevticheskii arkhiv 2022; 94(2): 216 doi: 10.26442/00403660.2022.02.201363
|
| 13 |
Ana Luiza C. de S. L. Oliveira, Raimundo Fernandes de Araújo Júnior, Thaís Gomes de Carvalho, Alan B. Chan, Timo Schomann, Filippo Tamburini, Lioe-Fee de Geus-Oei, Luis J. Cruz. Effect of Oxaliplatin-Loaded Poly (d,l-Lactide-co-Glycolic Acid) (PLGA) Nanoparticles Combined with Retinoic Acid and Cholesterol on Apoptosis, Drug Resistance, and Metastasis Factors of Colorectal Cancer. Pharmaceutics 2020; 12(2): 193 doi: 10.3390/pharmaceutics12020193
|
| 14 |
Jin Lee, Eun Mi Hong, Jung Han Kim, Jung Hee Kim, Jang Han Jung, Se Woo Park, Dong Hee Koh, Hyun Joo Jang. Ursodeoxycholic acid shows antineoplastic effects in bile duct cancer cells via apoptosis induction; p53 activation; and EGFR-ERK, COX-2, and PI3K-AKT pathway inhibition. Molecular Biology Reports 2021; 48(9): 6231 doi: 10.1007/s11033-021-06331-y
|
| 15 |
Sandra Appiah, Mike Revitt, Huw Jones, Milan Vu, Monique Simmonds, Celia Bell. Neurobiology of Chinese Herb Medicine. International Review of Neurobiology 2017; 135: 149 doi: 10.1016/bs.irn.2017.02.008
|
| 16 |
Jean-François Goossens, Christian Bailly. Ursodeoxycholic acid and cancer: From chemoprevention to chemotherapy. Pharmacology & Therapeutics 2019; 203: 107396 doi: 10.1016/j.pharmthera.2019.107396
|
| 17 |
Jin Lee, Eun Hong, Jung Kim, Jung Kim, Jang Jung, Se Park, Dong Koh. Ursodeoxycholic acid inhibits epithelial‑mesenchymal transition, suppressing invasiveness of bile duct cancer cells: An in vitro study. Oncology Letters 2022; 24(6) doi: 10.3892/ol.2022.13568
|
| 18 |
Zhiyong Shen, Jingjing Shao, Jianquan Zhang, Weixing Qu. Ultrasound cavitation enhanced chemotherapy: In vivo research and clinical application. Experimental Biology and Medicine 2020; 245(14): 1200 doi: 10.1177/1535370220936150
|
| 19 |
Ana Luiza C. de S.L. Oliveira, Luana Zerillo, Luis J. Cruz, Timo Schomann, Alan B. Chan, Thaís Gomes de Carvalho, Shirley Vitória de P. Souza, Aurigena A. Araújo, Lioe-Fee de Geus-Oei, Raimundo F. de Araújo Júnior. Maximizing the potency of oxaliplatin coated nanoparticles with folic acid for modulating tumor progression in colorectal cancer. Materials Science and Engineering: C 2021; 120: 111678 doi: 10.1016/j.msec.2020.111678
|
| 20 |
Kulvinder Kochar Kaur, Gautam Nand K. Allahbadia, Mandeep Singh. Mode of Actions of Bile Acids in Avoidance of Colorectal Cancer Development; and their Therapeutic Applications in Cancers - A Narrative Review. Journal of Pharmacy and Nutrition Sciences 2022; 12: 35 doi: 10.29169/1927-5951.2022.12.04
|
| 21 |
Weijian Li, Lu Zou, Shuai Huang, Huijie Miao, Ke Liu, Yajun Geng, Yingbin Liu, Wenguang Wu. The anticancer activity of bile acids in drug discovery and development. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1362382
|
| 22 |
Tien S. Dong, Jonathan P. Jacobs, Shehnaz K. Hussain. Microbial Profiles of Cirrhosis in the Human Small Intestine. Current Gastroenterology Reports 2019; 21(10) doi: 10.1007/s11894-019-0717-2
|
| 23 |
Wenbo Chen, Qisong Zhang, Ming Ding, Jingjing Yao, Yajuan Guo, Wenxin Yan, Shaofang Yu, Qinghong Shen, Min Huang, Yaqiu Zheng, Yuefang Lin, Ying Wang, Zhongqiu Liu, Linlin Lu. Alcohol triggered bile acid disequilibrium by suppressing BSEP to sustain hepatocellular carcinoma progression. Chemico-Biological Interactions 2022; 356: 109847 doi: 10.1016/j.cbi.2022.109847
|
| 24 |
Phuong Thao Nguyen, Keishi Kanno, Quoc Thang Pham, Yuka Kikuchi, Masaki Kakimoto, Tomoki Kobayashi, Yuichiro Otani, Nobusuke Kishikawa, Mutsumi Miyauchi, Koji Arihiro, Masanori Ito, Susumu Tazuma. Senescent hepatic stellate cells caused by deoxycholic acid modulates malignant behavior of hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2020; 146(12): 3255 doi: 10.1007/s00432-020-03374-9
|